Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein.
about
Twist: a molecular target in cancer therapeuticsRNA-based TWIST1 inhibition via dendrimer complex to reduce breast cancer cell metastasis.The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.Nanoparticle-mediated down-regulation of TWIST increases radiosensitivity of nasopharyngeal carcinoma cells via ERK pathwayTrefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signalingA poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer modelVaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.Role of the epithelial-mesenchymal transition in bladder cancer: from prognosis to therapeutic targetTwist promotes angiogenesis in pancreatic cancer by targeting miR-497/VEGFA axis.Multiple biological functions of Twist1 in various cancers.Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1.The role of phenethyl isothiocyanate on bladder cancer ADM resistance reversal and its molecular mechanism.FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence.
P2860
Q28294941-9C9F6D80-A562-46E2-8D6D-E29F8AD46AB6Q35119155-D0BD4464-CAD5-46C3-B3B1-B1612B28FE9DQ35740131-1C845FD2-558D-41FF-96BB-4686202B7843Q35758037-2A9807AA-EBBB-41B9-A551-B875E824BF18Q36261384-E2AEADE1-C16B-413D-8118-E0D672931CCCQ36414022-33BB811E-7D34-4562-95CE-5C4FEC519330Q36420021-A6DD5682-E17E-4C01-BFDF-58DE1E5DDDACQ37251810-3CBFBF22-CD7F-40EE-9734-8ED4AF2372B3Q37295501-75A1A628-1C93-4090-A04B-183D3581FA30Q37746336-C8E40EF7-C78B-4D77-9537-7B9CDDC11709Q38868217-5E3FCFCF-B0BD-49AF-B2F7-EE831349AB3DQ39180799-EAEE30AC-B9A4-4439-811A-03F7A96404DBQ51675463-39D4D931-5DB5-4BE3-9672-B00DB3255EF0
P2860
Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Twist confers chemoresistance ...... h upregulating P-glycoprotein.
@en
Twist confers chemoresistance ...... h upregulating P-glycoprotein.
@nl
type
label
Twist confers chemoresistance ...... h upregulating P-glycoprotein.
@en
Twist confers chemoresistance ...... h upregulating P-glycoprotein.
@nl
prefLabel
Twist confers chemoresistance ...... h upregulating P-glycoprotein.
@en
Twist confers chemoresistance ...... h upregulating P-glycoprotein.
@nl
P2093
P2860
P356
P1433
P1476
Twist confers chemoresistance ...... h upregulating P-glycoprotein.
@en
P2093
Dong Zhang
Jiancheng Zhou
Liang Liang
Luke S Chang
Xinyang Wang
P2860
P304
P356
10.1159/000341860
P577
2012-09-12T00:00:00Z